Can chronic gastritis impair acid secretion?

Based on the provided medical evidence, the claim that "chronic gastritis can impair acid secretion when inflammation damages gastric mucosal signaling or parietal cell function" is fully supported by medical science.

Critical Evidence & Mechanism

• Inflammatory Environment & Cytokines: Chronic gastritis—whether caused by Helicobacter pylori infection or autoimmune processes—induces a state of chronic inflammation in the gastric mucosa. This is characterized by a significant influx of pro-inflammatory cytokines, specifically interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α).
• Impairment of Parietal Cell Function: These pro-inflammatory cytokines act directly on parietal cells. They bind to specific receptors to inhibit acid secretion and directly suppress the expression of the gene encoding the H+,K+-ATPase proton pump, which is responsible for secreting stomach acid.
• Disruption of Mucosal Signaling: The inflammatory environment disrupts the essential hormonal feedback loop regulating acid production (the somatostatin-gastrin pathway). Specifically, inflammation impairs the function of D-cells (which release somatostatin to inhibit acid) and G-cells (which release gastrin to stimulate acid). The resulting drop in somatostatin levels leads to dysregulated, ineffective acid-regulatory signaling.
• Parietal Cell Loss (Atrophy): Over time, chronic, unaddressed inflammation and continuous exposure to these inflammatory cytokines trigger apoptosis (programmed cell death), leading to the physical loss of parietal cells (gastric atrophy).
• Clinical Outcome: The combination of direct functional inhibition of the remaining parietal cells, loss of parietal cell mass, and disrupted regulatory feedback loops ultimately impairs the stomach's overall capacity to secrete hydrochloric acid, leading to hypochlorhydria (low acid) or achlorhydria (absence of acid).

Bottom Line

Chronic gastritis directly impairs gastric acid secretion through a combination of inflammatory cytokine-mediated inhibition of parietal cells, destruction of parietal cell mass, and the disruption of critical hormonal signaling feedback loops (such as the somatostatin-gastrin axis).